What are Aclaris Therapeutics's profit margins?

Aclaris Therapeutics (ACRS) runs a 76.3% gross margin and a -961.9% operating margin, with a -832.6% net margin.

Where do Aclaris Therapeutics's ratios come from?

Every ratio is computed from Aclaris Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Aclaris Therapeutics ACRS Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	76.3%+3.1pp	73.3%-12.3pp	85.6%-0.2pp	85.8%-0.2pp	86%+0.9pp
Operating margin	-961.9%+14.0pp	-975.9%-2.0pp	-973.9%-101pp	-873.4%-79.8pp	-793.6%-35.4pp
Net margin	-832.6%-3.0pp	-829.6%+70.4pp	-900%-98.0pp	-802%-69.6pp	-732.4%-27.0pp
EBITDA margin	-956.8%+13.3pp	-970.1%+0.7pp	-970.8%-101pp	-870.1%-80.4pp	-789.7%-35.9pp
Returns
Return on equity	-48.4%+1.8pp	-50.2%+63.0pp	-113.2%-11.8pp	-101.4%-10.4pp	-91%-6.6pp
Return on assets	-35.1%-1.0pp	-34.1%+45.1pp	-79.2%-2.3pp	-76.9%-6.9pp	-70%-6.7pp
Return on invested capital	-69%+0.8pp	-69.8%+98.4pp	-168.2%-36.4pp	-131.8%-6.9pp	-124.9%-13.4pp
Efficiency
Asset turnover	0×0.0×	0×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Liquidity
Current ratio	4×+0.7×	3.4×-0.6×	3.9×0.0×	3.9×-1.2×	5.1×+1.1×
Quick ratio	4×+0.7×	3.4×-0.6×	3.9×0.0×	3.9×-1.2×	5.1×+1.1×
Cash ratio	1×+0.4×	0.7×-0.3×	1×0.0×	0.9×-0.5×	1.4×+0.6×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$1.12+32.6%	$0.84-14.1%	$0.98-8.9%	$1.07-8.7%	$1.18-41.5%
Valuation
Market capitalization	$685.75M+337%	$326.12M+58.4%	$205.83M+25.1%	$164.59M-0.5%	$165.47M-37.7%
Enterprise value	$659.07M+410%	$308.28M+68.6%	$182.82M+29.2%	$141.55M+2.9%	$137.59M-43.5%
Price / sales	82×+73.1×	41.7×+28.6×	13.1×+3.3×	9.8×+0.5×	9.3×-4.9×
Price / book	4.8×+3.7×	3.2×+1.4×	1.7×+0.5×	1.2×+0.1×	1.1×-0.6×
EV / sales	78.8×+71.5×	39.4×+27.8×	11.6×+3.2×	8.4×+0.7×	7.7×-5.3×
Earnings yield	-10.2%+72.8pp	-19.9%+48.9pp	-68.8%+13.0pp	-81.8%-3.1pp	-78.7%-28.9pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Aclaris Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Aclaris Therapeutics's profit margins?: Aclaris Therapeutics (ACRS) runs a 76.3% gross margin and a -961.9% operating margin, with a -832.6% net margin.
Where do Aclaris Therapeutics's ratios come from?: Every ratio is computed from Aclaris Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.